Literature DB >> 22799356

Effects of emodin extracted from Chinese herbs on proliferation of non-small cell lung cancer and underlying mechanisms.

Lin He1, Juan-Juan Bi, Qian Guo, Yin Yu, Xiu-Feng Ye.   

Abstract

To aim of this was to observe emodin-mediated cytotoxicity and its influence on Rad51 and ERCC1 expressionin non-small cell lung cancer (NSCLC). NSCLC cells were cultured in vitro with emodin at various concentrations (0, 25, 50, 75 and 100 μmol/L) for 48 h and the proliferation inhibition rate was determined by the MTT method. Then, NSCLC were treated with emodin (SK-MES-1 40 μmol/L, A549 70 μmol/L) or 20 μmol/L U0126 (an ERK inhibitor) for 48 h, or with various concentrations of emodin for 48 h and the protein and mRNA expressions of ERCC1 and Rad51 were determined by RT-PCR and Western blot assay, respectively. Emodin exerted a suppressive effect on the proliferation of NSCLC in a concentration dependent manner. Protein and mRNA expression of ERCC1 and Rad51 was also significantly decreased with the dose. Vacuolar degeneration was observed in A549 and SK-MES-1 cell lines after emodin treatment by transmission electron microscopy. Emodin may thus inhibited cell proliferation in NSCLC cells by downregulation ERCC1 and Rad51.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22799356     DOI: 10.7314/apjcp.2012.13.4.1505

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs.

Authors:  Xuemei Jia; Fang Yu; Junfeng Wang; Stephen Iwanowycz; Fatma Saaoud; Yuzhen Wang; Jun Hu; Qian Wang; Daping Fan
Journal:  Breast Cancer Res Treat       Date:  2014-10-14       Impact factor: 4.872

2.  ROS/p38/p53/Puma signaling pathway is involved in emodin-induced apoptosis of human colorectal cancer cells.

Authors:  Baorong Liu; Bo Yuan; Lan Zhang; Weimin Mu; Chongmin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 3.  The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers.

Authors:  Qing Zhang; Wen Wen Chen; Xue Sun; Die Qian; Dan Dan Tang; Li Lin Zhang; Mei Yan Li; Lin Yu Wang; Chun-Jie Wu; Wei Peng
Journal:  Int J Biol Sci       Date:  2022-05-16       Impact factor: 10.750

Review 4.  Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin.

Authors:  Esra Küpeli Akkol; Iffet Irem Tatlı; Gökçe Şeker Karatoprak; Osman Tuncay Ağar; Çiğdem Yücel; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

5.  Emodin prevents intima thickness via Wnt4/Dvl-1/β-catenin signaling pathway mediated by miR-126 in balloon-injured carotid artery rats.

Authors:  Jun-yi Hua; Yu-zhou He; Yun Xu; Xu-hong Jiang; Wu Ye; Zhi-min Pan
Journal:  Exp Mol Med       Date:  2015-06-26       Impact factor: 8.718

6.  Emodin Inhibits Colon Cancer Cell Invasion and Migration by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway.

Authors:  Juan Gu; Chang-Fu Cui; Li Yang; Ling Wang; Xue-Hua Jiang
Journal:  Oncol Res       Date:  2018-01-04       Impact factor: 5.574

7.  1-Hydroxyanthraquinones Containing Aryl Substituents as Potent and Selective Anticancer Agents.

Authors:  Nafisa S Sirazhetdinova; Victor A Savelyev; Tatyana S Frolova; Dmitry S Baev; Lyubov S Klimenko; Ivan V Chernikov; Olga S Oleshko; Teresa A Sarojan; Andrey G Pokrovskii; Elvira E Shults
Journal:  Molecules       Date:  2020-05-29       Impact factor: 4.411

Review 8.  Quinonoids: Therapeutic Potential for Lung Cancer Treatment.

Authors:  Hua-Zhong Ying; Chen-Huan Yu; Hao-Kun Chen; Huan-Huan Zhang; Jie Fang; Fang Wu; Wen-Ying Yu
Journal:  Biomed Res Int       Date:  2020-04-06       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.